Phytochemicals and inflammatory bowel disease: a review

Abstract

Gastrointestinal tract is the second largest organ in the body that mainly functions in nutrients and minerals intake through the intestinal barrier. Intestinal permeability maintains the circulation of minerals and nutrients from digested foods. Life and all the metabolic processes depend either directly or indirectly on proper functioning of GI tract. Compromised intestinal permeability and related disorders are common among all the patients with inflammatory bowel disease (IBD), which is a collective term of inflammatory diseases including Crohn’s disease and ulcerative colitis. Many synthetic drugs are currently in use to treat IBD such as 5-aminosalicylic acid corticosteroids. However, they all have some drawbacks as long-term use result in many complications. These problems encourage us to look out for alternative medicine. Numerous in vitro and in vivo experiments showed that the plant-derived secondary metabolites including phenolic compounds, glucosinolates, alkaloids, terpenoids, oligosaccharides, and quinones could reduce permeability, ameliorate-related dysfunctions with promising results. In addition, many of them could modulate enzymatic activity, suppress the inflammatory transcriptional factors, ease oxidative stress, and reduce pro-inflammatory cytokines secretion. In this review, we summarized the phytochemicals, which were proven potent in treating increased intestinal permeability and related complication along with their mechanism of action.

Keywords:

• Phytochemicals
• Intestinal permeability
• Inflammation
• Colitis
• Oxidative stress
• Gut microbiota

Acknowledgments

This research was supported by the Beijing Natural Science Foundation (Grant No. 7162028), the National Key Research and Development Program of China (Grant No. 2016YFD0400801), Beijing Excellent Talents Funding for Youth Scientist Innovation Team (2016000026833TD01), Support Project of High-level Teachers in Beijing Municipal Universities (IDHT20180506) and Beijing Technology and Business University Startup Fund (Grant No. LKJJ2016-18).

Disclosure statement

There are no conflicts to declare.